EAACI Congress 2023
BackMastocytosis: from bench to bedside
Friday 09 Jun, 16:45 PM -
18:15 PM CEST
Hall Y 03+04
ORAL Session
16:45
Identification of a highly selective small molecule KIT inhibitor that inhibits human mast cell survival and differentiation
16:57
Biological and clinical presentation of beta-tryptase allele duplication: Is there Hereditary beta-Tryptasemia?
17:09
In-vitro desensitization of primary human MCs using monoclonal anti-IgE stimulation results in changes in degranulation, pro-inflammatory cytokine and chemokine release
17:21
MRGPRX2 Small Molecule Antagonists Potently Inhibit Agonist-Induced Skin Mast Cell Degranulation
17:33
Relationship between serum tryptase levels and KIT D816V mutation frequency in peripheral blood of HaT- subjects: practical considerations
17:45
Symptom and Quality of Life Burden In Patients with Indolent Systemic Mastocytosis
